Model-Based Reverse Translation Between Veterinary and Human Medicine: The One Health Initiative
- PMID: 29178333
- PMCID: PMC5824107
- DOI: 10.1002/psp4.12262
Model-Based Reverse Translation Between Veterinary and Human Medicine: The One Health Initiative
Abstract
There is growing concern about the limitations of rodent models with regard to recapitulation of human disease pathogenesis. Computational modeling of data from humans and animals sharing similar diseases provides an opportunity for parallel drug development in human and veterinary medicine. This "reverse translational" approach needs to be supported by continuing efforts to refine the in silico tools that allow extrapolation of results between species.
© 2017 The Authors CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics.
Figures
References
-
- Waring, M.J. et al An analysis of the attrition of drug candidates from four major pharmaceutical companies. Nat. Rev. Drug Discov. 14, 475–486 (2015). - PubMed
-
- National Center for Emerging and Zoonotic Infectious Diseases (17 May 2012) . Centers for Disease Control and Prevention. <https://www.cdc.gov/ncezid/index.html> (2012).
-
- Jacob, J.A. Researchers turn to canine clinical trials to advance cancer therapies. JAMA 315, 1550–1552 (2016). - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
